Study evaluates the effectiveness of Aripiprazole in adolescents with schizophrenia
... Squibb Company (NYSE: BMY) atypical antipsychotic aripiprazole demonstrated significant improvement compared to p...ed study that evaluated the efficacy and safety of aripiprazole in adolescents, 13-17 years-old, with a primary diagnosis of schizophrenia. This study, sponsored b...Efficacy and safety of Aripiprazole as adjunctive therapy in major depressive disorder
In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in signif...ka Pharmaceutical Co., Ltd. atypical antipsychotic aripiprazole was added to antidepressants in patients who did not have an adequate response to ADT alone. (1)(Be...